- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2012
- Public Summary Document (PSD) March 2012 PBAC Meeting - PDF
Bortezomib – March 2012
Bortezomib, powder for injection 1 mg (solvent required), Velcade® - March 2012
Last updated
8 November 2023
